Immediate Impact
1 from Science/Nature 17 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Works of Xiaofei Yang being referenced
Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xiaofei Yang | 134 | 89 | 53 | 31 | 275 | |
| G. Olesen | 165 | 28 | 60 | 32 | 294 | |
| Alessandro Turra | 112 | 75 | 37 | 35 | 300 | |
| Misa Yoshida | 62 | 36 | 37 | 12 | 239 | |
| Kazuaki Yamanaka | 17 | 48 | 15 | 52 | 288 | |
| Manuela Tumino | 68 | 102 | 52 | 23 | 304 | |
| Elizabeth Grace | 27 | 85 | 26 | 23 | 322 | |
| Hiroshi Tohyama | 126 | 69 | 25 | 16 | 313 | |
| Haruyuki Fujita | 59 | 84 | 23 | 36 | 313 | |
| Diego Carbonell | 111 | 40 | 35 | 30 | 241 | |
| Mahmoud Hammad | 64 | 66 | 28 | 30 | 176 |
All Works
Loading papers...